WallStreetZenWallStreetZen
Analyst Ranking
Top 35%
#1561 out of 4529 analysts
Average Return
+7.86%
Win Rate
64%7 out of 11
Risk vs Reward
Poor
Good

Rachel Vatnsdal's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Amyris IncAMRSQ
+97.28%$1.84$0.05
2022-11-09 -
2023-08-18
Strong Sell
Danaher CorpDHR
+29.62%$192.65$249.72
2023-10-24 -
2024-03-28
Strong Buy
Danaher CorpDHR
+17.83%$211.94$249.72
2023-10-16 -
2024-03-28
Strong Buy
Danaher CorpDHR
+10.10%$226.81$249.72
2023-12-19 -
2024-03-28
Strong Buy
Henry Schein IncHSIC
+4.47%$72.29$75.52
2023-12-11 -
2024-03-28
Strong Buy

Rachel Vatnsdal Analyst Color

Get additional color on Rachel Vatnsdal's coverage of popular stocks

Rachel Vatnsdal's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Henry Schein IncHSIC
2Strong Buy$88.00+16.53%Maintains
23 days ago
Adaptive Biotechnologies CorpADPT
1Strong Buy$8.00+149.22%Maintains
a month ago
Danaher CorpDHR
4Strong Buy$270.00+8.12%Maintains
3 months ago
Myriad Genetics IncMYGN
2Strong Sell$14.00-34.33%Maintains
5 months ago
Revvity IncRVTY
2Hold$110.00+4.76%Maintains
5 months ago
Thermo Fisher Scientific IncTMO
1Strong Buy$670.00+15.28%Maintains
8 months ago
Amyris IncAMRSQ
2Strong SellN/AN/ADowngrades
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.